EcoDrugPlus

Histone Deacetylase 9

Ensembl ID : ENSPCTG00005001567
Gene Symbol: HDAC9
3 Cross references
234 Possible Orthologues:

Hydroxysteroid 17-Beta Dehydrogenase 7

Ensembl ID : ENSPCTG00005004854
Gene Symbol: HSD17B7
3 Cross references
265 Possible Orthologues:

Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 4

Ensembl ID : ENSPCTG00005012886
Gene Symbol: HCN4
3 Cross references
287 Possible Orthologues:

Hypocretin Receptor 2

Ensembl ID : ENSPCTG00005020624
Gene Symbol: HCRTR2
3 Cross references
201 Possible Orthologues:

Indoleamine 2,3-Dioxygenase 1

Ensembl ID : ENSPCTG00005011780
Gene Symbol: IDO1
1 Cross references
98 Possible Orthologues:

Inhibitor Of Nuclear Factor Kappa B Kinase Subunit Beta

Ensembl ID : ENSPCTG00005017974
Gene Symbol: IKBKB
3 Cross references
197 Possible Orthologues:

Inosine Monophosphate Dehydrogenase 2

Ensembl ID : ENSPCTG00005022090
Gene Symbol: IMPDH2
3 Cross references
199 Possible Orthologues:

Inositol Polyphosphate-5-Phosphatase D

Ensembl ID : ENSPCTG00005019085
Gene Symbol: INPP5D
1 Cross references
213 Possible Orthologues:

Integrin Subunit Alpha 2b

Ensembl ID : ENSPCTG00005018981
Gene Symbol: ITGA2B
3 Cross references
189 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSPCTG00005010998
Gene Symbol: ITGA4
3 Cross references
236 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSPCTG00005010618
Gene Symbol: ITGA5
3 Cross references
269 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSPCTG00005002403
Gene Symbol: ITGB1
3 Cross references
299 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).